
PEG-MGF
PEGylated Mechano Growth Factor
Also called PEG-MGF, pegylated mechano growth factor, IGF-1Ec
The local repair splice variant of IGF-1
MGF is a variant of IGF-1 that muscle produces itself after damage from training: a local repair signal. Natural MGF lasts minutes, so this version has a chemical tail attached to make it last hours, which is what the PEG in the name means. It has never been tested in a human trial.
A PEGylated form of mechano growth factor, a splice variant of IGF-1 (IGF-1Ec) that muscle produces in response to overload and damage. In laboratory and preclinical work MGF activates muscle stem cells to start repair. PEGylation extends its very short half-life. No human trial of PEG-MGF exists, and it is not an approved medicine.
- Half-life
- Hours (PEGylated); minutes for native MGF
- Status
- Not FDA-approved
Human trials published, with more underway
What PEG-MGF has been studied for
The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.
- Muscle repair
- The reason people look it up. MGF is released by damaged muscle to activate the stem cells that repair muscle fibres; the theory is that adding more amplifies that. Untested in people.
- Recovery from injury
- Discussed on the same reasoning. Extrapolated from the mechanism rather than shown in trials.
Mechanism of Action
How PEG-MGF works
PEG-MGF drives the early, satellite-cell phase of muscle repair:
- Muscle stem cell activation. In laboratory work the MGF splice variant signals resting muscle stem cells (satellite cells) to multiply, the first step in repairing fibres after damage.
- Distinct from systemic IGF-1. MGF is described as acting on the early repair phase rather than the sustained IGF-1 receptor growth signal.
- PEGylation. Native MGF is degraded within minutes; attaching polyethylene glycol slows clearance.
- Mechanically triggered. The body's own MGF is released by muscle overload.
PEG-MGF side effects: what studies reported
Little documented, and it is unclear how much of that reflects a mild compound and how much a compound that does little.
Reported outside trials
- Injection-site soreness
- A warm or flushed feeling
- Tiredness
- Occasional headache
Worth keeping an eye on
- It is related to IGF-1, so low blood sugar is theoretically possible, though it is reported far less than with IGF-1 itself
- It is a growth signal, which carries the same cancer-history caution as the rest of that family
Source: Reports outside trials; there is no human trial of PEG-MGF. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about PEG-MGF belong with a licensed clinician who knows your history.
Your Genetics & PEG-MGF
The genes involved in how PEG-MGF works
PEG-MGF works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.
MGF is a splice variant of the IGF1 gene. This promoter variant has been associated with baseline IGF-1 levels in population studies. Pathway context only.
ACTN3 · ••
The R577X variant determines whether alpha-actinin-3 is made in fast-twitch fibres, and is associated with sprint and power performance in athlete studies. Not studied with MGF.
IGF1R · ••
Builds the IGF-1 receptor; variants have been studied for association with IGF-1 levels and height. Pathway context only.
Myostatin restrains muscle growth, and the K153R variant has been studied for association with muscle traits, with mixed results. Pathway context only.
The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.
Which of these variants do you carry?
Your report reads the DNA file you already have against this research.
Often discussed alongside
Compounds that come up next to PEG-MGF in research and discussion. Each has its own page. None of this is a suggestion to combine them.

IGF-1
the gene it is spliced fromModerate EvidenceInsulin-like Growth Factor-1
The main mediator of growth hormone's effects. Most of what growth hormone does to muscle, tissue and growth is carried out by IGF-1, produced mainly in the liver. Most IGF-1 circulates bound to carrier proteins. As mecasermin (Increlex) it is an approved prescription drug for children with severe primary IGF-1 deficiency.
4
Gene variants
45+
Studies
Access
Access and legal status
PEG-MGF is not an FDA-approved drug. Products sold online as “research chemicals” are labelled not for human use, and FDA treats them as unapproved drugs when they are marketed for people. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.
Your DNA and PEG-MGF: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →
Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.
Worth knowing about PEG-MGF
Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.
- No human trial exists
- The mechanism is real and well described in muscle biology. Whether injecting a long-lasting version does anything useful in a trained human has never been tested.
- Not approved, and banned in sport
- It is not an approved medicine, and WADA prohibits growth factors including MGF at all times. Products sold under the name are unregulated.
Last updated
Frequently Asked Questions
What is the difference between PEG-MGF and IGF-1 LR3?
Both come from the IGF-1 system. MGF (the IGF-1Ec splice variant) is described in laboratory work as starting the repair phase by activating muscle stem cells, while IGF-1 LR3 is an engineered long-acting version of the main hormone. Neither has been tested in a human trial for muscle.
Why is MGF PEGylated?
Native MGF has a very short half-life: it is a local, brief signal in muscle. Attaching polyethylene glycol (PEGylation) slows its breakdown.
Do genes affect PEG-MGF response?
No study has tested whether any genotype changes response to PEG-MGF. IGF1, ACTN3, IGF1R and MSTN variants have been associated with muscle or IGF-1 traits in human studies. A DNA report can show which versions you carry and what that research does and does not show.
Learn more about PEG-MGF
Your DNA and PEG-MGF
What the research says about your variants.
The report
Which PEG-MGF variants do you carry?
Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.
Read my DNA, $99